Drug
Vofopitant clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
3 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses vofopitant is read from its arms, and is right about nine times in ten.
Testing it · 3
- Substance P Antagonist in the Treatment of Posttraumatic Stress DisorderCompletedPhase 2Baylor College of MedicineNCT00383786Written as NK1 Antagoist (GR205171)
- A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy SubjectsTerminatedPhase 1GlaxoSmithKlineNCT00907985Written as Vofopitant
- A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary InsomniaCompletedPhase 2GlaxoSmithKlineNCT00606697Written as GR205171
Codes
What other systems call vofopitant · ClinicalTrials.gg INT003949
- MeSH (NLM) C103207vofopitantConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) K08BK043YSVOFOPITANTConfirmed FDA, NLM, Wikidata
- Wikidata Q21098911vofopitantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72949VofopitantOne source FDA
- DrugBank DB12436One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C103207 | vofopitant | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | K08BK043YS | VOFOPITANT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q21098911 | vofopitant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72949 | Vofopitant | One source FDA |
| DrugBank | DB12436 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.